IMUGENE LTD

0.041

0.000

Volume:4.28M

Turnover:171.44K

Market Cap:22.50M

PE:-0.13

High:0.042

Open:0.041

Low:0.039

Close:0.041

52wk High:0.460

52wk Low:0.037

Shares:548.90M

Float Shares:254.20M

Volume Ratio:0.60

T/O Rate:1.69%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.323

EPS(LYR):-0.323

ROE:-313.99%

ROA:-123.50%

PB:2.50

PE(LYR):-0.13

Loading ...

Overview Company News Filings

Concept

Pharmaceutical Companies+1.34%

Capital Flow

Inflow:

Outflow:

News

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sgp.itiger.com/stock/IMU.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMU.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMU.AU\",,,,,undefined,":{"symbol":"IMU.AU","market":"AU","secType":"STK","nameCN":"IMUGENE LTD","latestPrice":0.041,"timestamp":1791349920000,"preClose":0.041,"halted":0,"volume":4284215,"delay":0,"changeRate":0,"nameEN":"IMUGENE LTD","floatShares":254199099,"shares":548901511,"eps":-0.323022,"marketStatus":"Closed","change":0,"latestTime":"10-07 16:12:00 AEDT","open":0.041,"high":0.042,"low":0.039,"amount":171444,"amplitude":0.073171,"askPrice":0.044,"askSize":317493,"bidPrice":0.039,"bidSize":343809,"shortable":3,"etf":0,"ttmEps":-0.323022,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791414000000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.041,"openAndCloseTimeList":[[1791327600000,1791349200000]],"volumeRatio":0.598015,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"IMU.AU","preClose":0.041,"auctionPrice":0.041,"auctionVolume":273729,"auctionTime":1791349802493,"referencePrice":0.041,"referenceTime":1791360000925,"auction":3,"marketStatus":"盘后竞价","timestamp":1791349802493}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMU.AU\",,,,,undefined,":{"symbol":"IMU.AU","floatShares":254199099,"roa":"-123.50%","roe":"-313.99%","lyrEps":-0.323022,"volumeRatio":0.598015,"shares":548901511,"dividePrice":0,"high":0.042,"amplitude":0.073171,"preClose":0.041,"low":0.039,"week52Low":0.037,"pbRate":"2.50","psRate":"10.79","week52High":0.46,"institutionHeld":0,"latestPrice":0.041,"committee":0.039794,"eps":-0.323022,"divideRate":0,"volume":4284215,"delay":0,"ttmEps":-0.323022,"open":0.041,"prevYearClose":0.365,"prevWeekClose":0.037,"prevMonthClose":0.042,"prevQuarterClose":0.042,"fiveDayClose":0.042,"twentyDayClose":0.063,"sixtyDayClose":0.096},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMU.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-07-02","symbol":"IMU.AU","type":"split","dateTimestamp":1751378400000,"forFactor":34,"toFactor":1,"ratio":34}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMU.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMU.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673066421","title":"Imugene Ltd-DR John Le Gall Appointed Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2673066421","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673066421?lang=en_us&edition=fundamental","pubTime":"2026-10-07 06:18","pubTimestamp":1791325117,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nTUE7BLDWY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMU.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673172772","title":"Australia's Imugene Rises on Fresh Responses in Blood Cancer Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2673172772","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673172772?lang=en_us&edition=fundamental","pubTime":"2026-10-05 12:24","pubTimestamp":1791174282,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Imugene rises on fresh responses in blood cancer drug trial** Shares of Australia's Imugene LimitedIMU.AXrise as much as 35.1% to A$0.05, their highest level since September 17** Stock on track for its biggest intraday pct rise since July 1, if current trend holds** Clinical-stage cell therapy coreports two additionalpatient responses in Phase 1b trial of blood cancer therapy azer-cel** Patient responses included one complete response in mantle cell lymphoma and one partial response in chronic lymphocytic leukemia** All four patients had previously failed BTK inhibitor therapy - a common class of blood-cancer drug** Says therapy has shown 75% overall response rate across 55 patients evaluated in the study** Stock down nearly 88% YTD, including session's moves","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nL4N45R06A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","IMU.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654093770","title":"Imugene Ltd Says Leslie Chong Resigns as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2654093770","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654093770?lang=en_us&edition=fundamental","pubTime":"2026-07-27 09:53","pubTimestamp":1785117224,"startTime":"0","endTime":"0","summary":"BRIEF-Imugene Ltd Says Leslie Chong Resigns As CEOJuly 27 (Reuters)-Imugene LtdIMU.AX:CEO RESIGNATIONLESLIE CHONG RESIGNS AS CEO OF IMUGENELESLIE CHONG STEPS DOWN AS MANAGING DIRECTOR AND CEO FOR PERSONAL REASONSFurther company coverage:IMU.AX","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nTUE1D4RX7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","IMU.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654558060","title":"Imugene - Leslie Chong Resigns as CEO of Imugene","url":"https://stock-news.laohu8.com/highlight/detail?id=2654558060","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654558060?lang=en_us&edition=fundamental","pubTime":"2026-07-27 07:39","pubTimestamp":1785109176,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260726:nTUE1D4RX7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","IMU.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/IMU.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Pharmaceutical Companies","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":0.013363}]}}